Rare diseases
Investigational molecules
Locations
Halom Utca 10, 1102 Budapest, Hungary
PVN Kutato Kft. in Budapest, Hungary specialises in clinical trials of conditions such as Type 2 diabetes mellitus, Obesity, Arteriosclerosis, Chronic kidney disease, and other specialisations. This site conducts important research.
At PVN Kutato Kft. investigators are evaluating innovative treatments aimed at reducing the burden of atherosclerotic cardiovascular disease, preventing heart failure, and improving lipid profiles in patients with high LDL‑C. The studies test new drug combinations to lower cardiovascular risk and to manage conditions such as chronic kidney disease and hyperlipidemia.
The site is conducting 10 trials with 3 investigators, focusing on cardiovascular health across diverse patient groups.
Research at PVN Kutato Kft. targets metabolic disorders, including type 2 diabetes, obesity, and overweight conditions. Trials assess the efficacy of new glucose‑lowering agents, weight‑loss therapies, and combination regimens to improve glycemic control and promote body‑weight reduction.
Across 10 clinical studies, the team of 3 investigators explores metabolic health solutions for patients with diabetes and excess weight.
Clinical trials currently enrolling participants at this site.
HungaryEfficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes
HungaryA Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes
HungaryA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
HungaryEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
HungaryA study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
HungaryStudy of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels
HungaryStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
HungaryStudy comparing cagrilintide and semaglutide versus tirzepatide in people with type 2 diabetes taking metformin or SGLT2 inhibitor
HungaryA study testing cagrilintide and semaglutide compared to placebo in people with type 2 diabetes not well controlled by diet and exercise
HungaryStudy on the Effectiveness and Safety of Gliclazide MR, Dapagliflozin, and Metformin for Patients with Type 2 Diabetes Not Well Controlled with Dapagliflozin
HungaryMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
